June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Azobenzene-based BENAQ photoswitch confers light-sensitivity to degenerating and WT canine retinas.
Author Affiliations & Notes
  • Sergei Nikonov
    Dept. of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Roman Nikonov
    Division of Experimental Retinal Therapies, Dept. of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Natalia Dolgova
    Division of Experimental Retinal Therapies, Dept. of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Richard H Kramer
    Dept. of Molecular and Cell Biology, University of California, Berkeley, California, United States
  • Russell Van Gelder
    Depts. of Ophthalmology, Pathology, and Biological Structure, University of Washington, Seattle, Washington, United States
  • Gustavo D Aguirre
    Division of Experimental Retinal Therapies, Dept. of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • William A Beltran
    Division of Experimental Retinal Therapies, Dept. of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Sergei Nikonov, None; Roman Nikonov, None; Natalia Dolgova, None; Richard Kramer, None; Russell Van Gelder, None; Gustavo Aguirre, None; William Beltran, None
  • Footnotes
    Support  R24EY023937, R01EY06855, P30EY01583, Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4285. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sergei Nikonov, Roman Nikonov, Natalia Dolgova, Richard H Kramer, Russell Van Gelder, Gustavo D Aguirre, William A Beltran; Azobenzene-based BENAQ photoswitch confers light-sensitivity to degenerating and WT canine retinas.. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4285.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Following results demonstrating BENAQ effectiveness at conferring light sensitivity to mouse (Tochitsky et al. Sci. Reports, 2017) and dog retinas with end stage retinal degeneration, the aim of the current study was to examine whether BENAQ is also effective in canine retinas at earlier stages of disease when there is a reduced yet persistent number of photoreceptors.

Methods : Retinal ganglion cell (RGC) firing rates were recorded ex-vivo using a multi electrode array technique from 3 mutant rcd1/PDE6B dogs (14-17 weeks of age), 3 mutant xlpra2/RPGR dogs (29-31 wks), and 3 WT dogs (18-24 wks) before, during, and after application of 20 μM of BENAQ (in Ames) and during perfusion with synaptic blockers following BENAQ application. Retinas were stimulated with calibrated flashes of 455 nm light.

Results : All BENAQ-treated retinas including those of WT dogs demonstrated robust light responses during and after BENAQ application. BENAQ profoundly changed the kinetics and amplitudes of the pre-existing light-responses in all WT and mutant retinas, increasing intensity thresholds by up to 10x and simultaneously increasing maximum response amplitudes at the bright intensities (> 1016 photons cm-2 s-1). BENAQ-driven responses included a fast ON- and a slower suppression components. The fast disappearance of the ON-response at the flash offset while suppression was still present resulted in what appeared as a negative OFF-response. None of the recorded retinas demonstrated “suppression” responses prior to the BENAQ application. Synaptic blockers reduced but did not eliminate ON- and suppression responses, suggesting that BENAQ-driven responses have a component due to the direct action of BENAQ on RGCs and a component due to the synaptically transmitted inputs from the BENAQ-targeted cells upstream of RGCs.

Conclusions : BENAQ confers light-sensitivity to degenerating retinas of two naturally-occurring canine forms of inherited retinal degeneration before a complete loss of photoreceptor cells, as well as in normal/non-degenerated canine retinas. BENAQ-driven responses have lower sensitivity and larger maximum amplitude compared to the pre-existing cone-driven responses. BENAQ has multiple cellular targets in the retina including RGCs and upstream neurons. BENAQ should only be considered as a therapeutic strategy in patients with end stage retinal degeneration.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×